Literature DB >> 14500539

Identification of an inducible bacteriophage in a virulent strain of Streptococcus suis serotype 2.

J Harel1, G Martinez, A Nassar, H Dezfulian, S J Labrie, R Brousseau, S Moineau, M Gottschalk.   

Abstract

Streptococcus suis infection is considered to be a major problem in the swine industry worldwide. Most virulent Canadian isolates of S. suis serotype 2 do not produce the known virulence markers for this pathogen. PCR-based subtraction hybridization was adapted to isolate unique DNA sequences which were specific to virulent strains of S. suis isolated in Canada. Analysis of some subtracted DNA clones revealed significant homology with bacteriophages of gram-positive bacteria. An inducible phage (named Ss1) was observed in S. suis following the incubation of the virulent strain 89-999 with mitomycin C. Phage Ss1 has a long noncontractile tail and a small isometric nucleocapsid and is a member of the Siphoviridae family. Ss1 phage DNA appears to be present in most Canadian S. suis strains tested in this study, which were isolated from diseased pigs or had proven virulence in mouse or pig models. To our knowledge, this is the first report of the isolation of a phage in S. suis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500539      PMCID: PMC201037          DOI: 10.1128/IAI.71.10.6104-6108.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  A high incidence of prophage carriage among natural isolates of Streptococcus pneumoniae.

Authors:  M Ramirez; E Severina; A Tomasz
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

2.  Evolution of a Lytic Bacteriophage via DNA Acquisition from the Lactococcus lactis Chromosome.

Authors:  S Moineau; S Pandian; T R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

3.  Expression, regulation, and mode of action of the AbiG abortive infection system of lactococcus lactis subsp. cremoris UC653

Authors: 
Journal:  Appl Environ Microbiol       Date:  1999-01       Impact factor: 4.792

4.  Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries.

Authors:  H J Wisselink; H E Smith; N Stockhofe-Zurwieden; K Peperkamp; U Vecht
Journal:  Vet Microbiol       Date:  2000-06-01       Impact factor: 3.293

5.  Isolation and characterization of a Streptococcus thermophilus plasmid closely related to the pMV158 family.

Authors:  N Turgeon; S Moineau
Journal:  Plasmid       Date:  2001-05       Impact factor: 3.466

6.  Meningitis caused by Streptococcus suis in humans.

Authors:  J P Arends; H C Zanen
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

7.  Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2.

Authors:  M Gottschalk; A Lebrun; H Wisselink; J D Dubreuil; H Smith; U Vecht
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

8.  Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis.

Authors:  A A Jacobs; P L Loeffen; A J van den Berg; P K Storm
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins.

Authors:  S Quessy; J D Dubreuil; M Caya; R Higgins
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Identification of two proteins associated with virulence of Streptococcus suis type 2.

Authors:  U Vecht; H J Wisselink; M L Jellema; H E Smith
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more
  7 in total

1.  Different genetic elements carrying the tet(W) gene in two human clinical isolates of Streptococcus suis.

Authors:  Claudio Palmieri; Maria Stella Princivalli; Andrea Brenciani; Pietro E Varaldo; Bruna Facinelli
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

2.  Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.

Authors:  Fang Tang; Dezhi Li; Haojin Wang; Zhe Ma; Chengping Lu; Jianjun Dai
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

3.  Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen.

Authors:  Roberto Vázquez; Mirian Domenech; Manuel Iglesias-Bexiga; Margarita Menéndez; Pedro García
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

4.  The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.

Authors:  Daniel B Gilmer; Jonathan E Schmitz; Mya Thandar; Chad W Euler; Vincent A Fischetti
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 5.  From Farm to Fork: Streptococcus suis as a Model for the Development of Novel Phage-Based Biocontrol Agents.

Authors:  Emmanuel Kuffour Osei; Jennifer Mahony; John G Kenny
Journal:  Viruses       Date:  2022-09-09       Impact factor: 5.818

6.  Lysogenic Streptococcus suis isolate SS2-4 containing prophage SMP showed increased mortality in zebra fish compared to the wild-type isolate.

Authors:  Fang Tang; Wei Zhang; Chengping Lu
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

7.  Complete Genome Sequence of the Streptococcus suis Temperate Bacteriophage ϕNJ2.

Authors:  Fang Tang; Alex Bossers; Frank Harders; Chengping Lu; Hilde Smith
Journal:  Genome Announc       Date:  2013-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.